Senate Majority Leader John Thune (R-SD) said he supports holding Dr. Anthony Fauci in contempt of Congress after Fauci refused to answer committee questions.

The move signals a deepening confrontation between Republican leadership and the former public health official over the transparency of the federal government's pandemic response. It suggests that legal maneuvers to compel testimony may be the next step for the Senate.

During a hearing in Washington, D.C., on Wednesday, Fauci invoked the Fifth Amendment to decline answering questions related to the COVID-19 pandemic [1, 2]. The refusal prompted immediate backlash from GOP leaders who argue that the public deserves full accountability for the decisions made during the global health crisis.

"What he did today in front of that committee was inexcusable," Thune said [1].

This clash occurs six years since the start of the pandemic [3]. Republican senators have spent years questioning the origins of the virus and the efficacy of federal mandates, but the use of the Fifth Amendment creates a significant legal barrier to obtaining direct testimony.

Thune's position aligns with other Republican members who believe that invoking constitutional protections in a congressional oversight setting obstructs the legislative process. The Senate is now weighing a formal vote to hold Fauci in contempt [2, 4].

Fauci's decision to remain silent on specific pandemic-related queries has intensified the political divide over his legacy. While supporters view him as a dedicated civil servant, critics argue his refusal to answer questions confirms a lack of transparency regarding the U.S. government's actions [1, 2].

“"What he did today in front of that committee was inexcusable."”

The push for a contempt citation reflects the ongoing political struggle to establish a definitive historical record of the U.S. pandemic response. By invoking the Fifth Amendment, Fauci has moved the conflict from a policy debate to a legal one, potentially setting a precedent for how former high-ranking health officials interact with congressional oversight committees.